Page 81 - Forbes - Asia (September 2018)
P. 81

HEALTHTECH
















































































                                                                                                              HeartFlow CEO John Stevens at the Grand
                                                                                                         American Hotel in Salt Lake City. He says he quit
                                                                                                            being a heart surgeon because he could help
                                                                                                                      more people as an entrepreneur.


                 “I don’t wake up in the middle of the night thinking can we       port is “fundamentally  awed.”
              do an FFR in more people,” says Ethan J. Weiss, a cardiologist          here are also many believers, like Robert D. Saian, a cardi-
              at University of California, San Francisco.                          ologist at Beaumont Health in Royal Oak, Michigan, who has
                 hen there are technical doubts. HeartFlow calculates  ow          received $3,000 from HeartFlow for travel. “Initially, I was one
              by looking at the shape of a blood vessel, as one might guess        of the worst skeptics, but now I’m completely converted and I
              the speed of a stream from the shape of its banks. “Trying to        think it’s amazing technology,” he says. He’s used HeartFlow for
              measure FFR from a CT scan is like trying to run a marathon          the past three years on 2,000 patients.
              on one leg,” says Darrel Francis, a professor of cardiology at          Most large U.S. insurers pay for HeartFlow’s test, as does the
              the National Heart & Lung Institute in the U.K. According to         ever-skeptical U.K. National Health Service. Medicare is paying
              a report in JAMA Cardiology, analyses that used CT scans to          for it except in the western U.S. Says Stevens, the chief execu-
              measure  ow, including but not limited to HeartFlow, were            tive, “At the end of the day, the data will win.”  F
              much less accurate in sicker patients. HeartFlow says the re-        Matthew Herper contributed to this story.
            TIM PANNELL FOR FORBES


                                                                                                                      SEPTEMBER 2018     FORBES ASIA     |     79
   76   77   78   79   80   81   82   83   84   85   86